|
PRISMAP - The European medical isotope programme: Production of high purity isotopes by mass separation PRISMAP proposes to federate the key European intense neutron sources, isotope mass separation facilities, and high-power accelerators and cyclotrons, together with leading biomedical research institutes and hospitals active in the translation of the emerging radionuclides into medical diagnosis and treatment. It will create a sustainable source of high purity grade new radionuclides and a single entry-point for a fragmented user community, distributed amongst universities, research centres, industry and hospitals. It is thus striving to create a paradigm shift in the early-phase research on radiopharmaceuticals, targeted drugs for cancer, theranostics, and personalised medicine in Europe, inspired from a similar program, the NIDC, already launched by the Department of Energy in the USA. |
Coordinator: CERN, Switzerland Scientist in Charge from CERN: Full costs of the project: 5 M€ EU funding: 5 M€ EU funding for CERN: 1 M€ 1 March 2021 - 28 February 2025 |